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INTRODUCTION 
Drugs  that  affect skeletal muscle function  include two  
different  therapeutic groups : those used during  
surgical procedures and in the intensive care  unit (ICU)  
to  produce  muscle paralysis (neuromuscular blockers ) 
and those used  to reduce spasticity in a variety of 
painful conditions (spasmolytics) . Neuromuscular 
blocking agents act peripherally at neuromuscular 
junction to  reduce  muscle tone and  cause paralysis of 
skeletal muscles.  They are used mainly as a part of  
balanced  anesthesia to  provide muscle relaxation 
during surgery.
 
The most important use of 
neuromuscular blockers is as adjuvant to general 
anaesthesia where adequate muscle relaxation can be 
achieved at lighter plane, particularly of abdominal wall 
and lower limbs so that operative manipulations become 
easier. This situation minimizes the risk of respiratory 
and cardiovascular depression besides shortening the 
post-anaesthetic recovery period because a much lighter 
level of anaesthesia  is sufficient. These drugs block the  
post-synaptic actions of acetylcholine  at motor end 
plate   and are generally referred to as skeletal muscle 
relaxants or at times simply as muscle relaxants  
because smooth muscle relaxants are specifically 
designated  as  either antispasmodics or  vasodilators.
1
   
Neuromuscular blockers drugs which are acting 
peripherally are called non-depolarizing blockers 
(competitive blocker) and persistant depolarizing 
blockers  based on the mechanism of action. Directly 
acting muscle relaxants (dantrolene) and centrally 
acting muscle relaxants (mephenesin and its congeners ) 
are the other types of skeletal muscle relaxants.
2
 
Competitive blockers (curare like drugs) are bulky 
quaternary compounds with two positively charged 
nitrogen. They shadow over the NM receptor, and  
prevent its binding to acetylcholine. As a result the 
conformational change in the NM receptor, which is 
needed for the opening of the Na
+
 channel is prevented. 
Therefore in the absence of end plate potential, the 
motor nerve  cannot  elicit the contractions and  hence 
skeletal muscle relaxation ensues. They do not cause 
depolarization by themselves but prevent endplate 
depolarization by acetylcholine. The antagonism is 
surmountable and reversal can be achieved with 
anticholinesterase drugs  like neostigmine. At high 
concentrations these directly block the Na
+
 channels 
which further causes weakening of neuromuscular 
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transmission  but at the same time reduces the ability of 
drug like  neostigmine  to reverse  the  actions of  non-
depolarizing muscle relaxants.   
In the multiple innervated contracture muscle like rectus 
abdominis muscle of frog, stimulation is prolonged  
resulting in sustained contraction.  
Non-depolarizing neuromuscular blocking agents 
produce flaccid paralysis and depolarizing agents 
produce spastic  paralysis. The main purpose of this  
study is to find out the  potency and of three commonly 
used neuromuscular non-depolarizing muscle relaxants 
like  pancuronium, vecuronium and atracurium 
 
in  vitro  
experimental  models  of  isolated frog rectus  
abdominis muscle .
3                                                                              
MATERIAL AND METHODS   
The  study  was  conducted  in   amphibian laboratory  
in the  department   of pharmacology , kamineni   
institute of  medical sciences,  narketpally , Andhra 
Pradesh  during  the period 1/8/2011 to 12/7/2012 . 
Frogs (Rana tigrina )  30  in number ,  weighing  150-
250 grams,  reared in central animal house  of  the     
kamineni   institute of  medical sciences  were used.  
The  present  study  was  approved  by  institutional  
animal  ethics  committee. 
Dissecting and Mounting of the tissue 
The standard  procedure  for  dissecting  and  mounting 
of  the tissue  is  followed.  A pithed frog (150-250 
grams) is  laid  on  its back  in a  tray. The  skin   on  the  
abdominal wall  is removed. The two  recti  muscles  in  
the  midline  extending  from   xiphisternum   to  the  
symphysis pubis  is   identified. The borders   of  
muscle  is dissected  out  from  the adjacent   wall  
muscles. The  two   recti muscles  are separated  with  a 
scissors. With  the  help  of  a needle  and  thread , a  
tight  ligature  round  the muscle is applied just  above  
the  symphysis   pubis  and  just  below the  
xiphisternum with  a  long thread  attached. The muscle 
strip is cut  and  removed from  the symphysis pubis  
and  xiphisternum. 
Mounting 
The  lower end  of  the  isolated rectus muscle is  tied 
closely to the  bent  portion of   the (lower end) tissue   
holder  at its centre . The upper end of  the  tissue with 
the  long thread  is tied  to  the simple lever placed 
above , so that  when the  muscle contacts , the writing 
point goes  up. During the  dissection and  attaching 
muscle to the tissue holder, the  muscle must be  kept  
moist with the frog ringer solution. Allow the  tissue to 
relax for  30minutes and wash  the tissue for 2 minutes  
by  allowing  the  nutrient solution (ringer ) in  and out 
of inner  organ bath. The  normal contraction of   the  
isolated rectus muscle is recorded  for  three  minutes by 
using frog ringer solution and tissue is washed with frog 
ringer solution in between each contraction and relaxed 
for 2 minutes.
4
 Acetylcholine  32µg  was added  and  
height   of  contraction  of rectus muscle was  recorded  
to  test  the  sensitivity of  the tissue. Then  
pancuronium  0.06mg/litre  was  added  to  inner organ 
bath  and  height of contraction  was  recorded.  The  
above  proceedure  was  repeated  with  acetylcholine 
different concentrations  64 µg,128 µg, 256µg, 
512µg  by  adding   Pancuronium    dose concentrations 
of  0.12mg/litre  and 0.25mg/litre after each 
acetylcholine dose. Sensitivity of  vecuronium dose 
concentrations  0.06 mg/lit, 0.12 mg/lit , 0.25 mg/lit   
and  atracurium dose concentrations  0.06 mg/lit, 0.12 
mg/lit  and  0.25 mg/lit  was  also  tested  by  using 
the  above  procedure. 
 
Table 1: Grouping of  animals  for  comparision  of  potency  of  drugs 
Animals  were  divided  in to  5 groups  each  containing  6  animals  (n=6 in each group , a  total  of  5 groups ,  30 
frogs required )  
 Groups  (n=30 ) Drugs  Concentration of drugs  
 
        1 Frog ringer                       - 
                       
        2 Acetylcholine  32µg,   64 µg ,    128 µg, 256µg,     
512µg 
        3 Pancuronium 0.06 mg/lit,    0.12 mg/lit,  0.25 
mg/lit 
        4 Vecuronium 0.06 mg/lit,    0.12 mg/lit, 0.25 
mg/lit 
        5 Atracurium 0.06 mg/lit,    0.12 mg/lit , 0.25 
mg/lit 
 
RESULTS   
As  shown  in  the  (table-2)  pancuronium  different 
dose  concentrations  treatment has decreased  
acetylcholine  induced  contraction  of  frog  rectus 
abdominus muscle  from         0 minute to 90 minute. 
Further    (table-3 and  table -4)  vecuronium  and  
atracurium  treated animals  group  also  decreased  
acetylcholine contractions compared to 0 minute. The  
above observations  indicate   stastically   significant 
(P˂0.001).
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Table 2 : Comparision of  antagonist effect of  pancuronium in minutes  (mean ± sd)  with  different concentrations  
(0.06mg/lit , 0.12mg/lit and  0.25mg/lit ) against acetylcholine height of  contractions 
Frog ringer, acetylcholine,   pancuronium height of contractions  response in mm 
Treatment/ 
Minutes 
Frog ringer  ACH  ACH + 
Pancuronium 
0.06mg/lit 
ACH + 
Pancuronium 
0.12mg/lit 
ACH + 
Pancuronium 
0.25mg/lit 
P value 
0 min 5.91±0.41 11.17±4.99  8.10±6.07  4.09±5.06 2.00±3.04 0.04 
15min 5.08±0.35 22.33±11.11  17.83±7.83  14.83±1.17  10.00±4.03 0.05 
30min 5.25±0.25 29.33±9.69  10.17±9.45  2.33±2.42  0.40±0.55  0.001* 
60min 5.15±0.22 36.67±8.24  21.67±3.26  5.50±2.56  1.40±0.55  0.001* 
90min 5.30±0.20 43.33±9.44  26.33±4.76  10.00±2.09  4.80±1.30  0.001* 
 ACH= Acetylcholine,   P˂0.001 is highly significant  
 
Table 3 : Comparision of  antagonist effect of  vecuronium in minutes (mean ±sd)  with  different concentrations  
(0.06mg/lit , 0.12mg/lit and  0.25mg/lit ) against acetylcholine height of  contractions 
Frog ringer ,  acetylcholine,   pancuronium height of contractions  response in mm 
Treatment/ 
Minutes 
Frog ringer 
    ACH 
Ach + 
Vecuronium 
0.06mg/lit  
Ach + 
Vecuronium 
0.12mg/lit  
Ach + 
Vecuronium 
0.25mg/lit  
P value 
    0 min 5.00±0.38  14.00±7.09  11.33±1.03  8.00±3.09 5.00±2.01 0.04 
   15 min 5.00±0.30 24.33±1.03  17.33±5.89  11.17±0.17  8.00±3.06 0.05 
   30min  5.20±0.24 35.67±10.84  11.17±6.85  3.33±3.08  1.00±1.55  0.001* 
   60min 5.10±0.20 43.50±9.61  24.83±7.33  10.33±6.69  4.20±3.54  0.001* 
   90min 5.25±0.15 51.83±7.83  25.83±2.32  15.33±8.41  5.00±5.87  0.001* 
 
Table 4 : Comparision of  antagonist effect of  atracurium in minutes (mean ±sd)  with  different concentrations  
(0.06mg/lit , 0.12mg/lit and  0.25mg/lit ) against acetylcholine height of  contractions 
Frog ringer ,  acetylcholine,   pancuronium height of contractions  response in mm 
Treatment/ 
Minutes 
Frog 
ringer Ach  
     Ach +
 
Atracurium 
0.06mg/lit 
Ach + 
Atracurium 
0.12mg/lit  
Ach + 
Atracurium
 
0.25mg/lit  
P value 
0min 5.45±0.40 16.83±3.32  13.00±3.58  9.33±2.82  3.00±1.03  0.04 
    15min 5.12±0.28 19.83±4.45  13.00±5.67  10.67±1.03  6.00±2.04  0.05 
     30min 5.30±0.22 25.17±6.85  13.00±8.29  5.00±2.53  2.33±1.97  0.001* 
     60min 5.15±0.15 35.83±10.65  22.33±8.21  9.83±4.9  4.83±2.93  0.001* 
     90min  5.28±0.10 41.17±12.70  28.17±9.58  16.67±7.03  5.33±4.27  0.001* 
 
Table 5 : IC50   (Half maximal inhibitory concentration )  value  of   pancuronium  different  concentrations   0.06mg/lit, 
0.12mg/lit and 0.25mg/lit   against   acetylcholine  (submaximal dose )  dose  256μg/30ml  frog ringer solution. 
Number of frogs   Mean± sd  
    6 0.066 ± 0.0046 
Sd – Standard deviation 
Table 6 : IC50  (Half  maximal inhibitory concentration )  value  of   vecuronium  different  concentrations  0.06mg/lit, 
0.12mg/lit and 0.25mg/lit  against  acetylcholine  (submaximal dose ) dose  256μg/30ml frog ringer solution. 
Number of frogs   Mean± sd  
    6 0.067 ± 0.0035 
    
Table 7 :  IC50  (Half maximal inhibitory concentration )  value   of   atracurium  different  concentrations  0.06mg/lit, 
0.12mg/lit and 0.25mg/lit  against   acetylcholine (submaximal dose ) dose  256μg/30ml frog ringer solution. 
Number of frogs   Mean± sd 
    6 1.18 ± 0.1204 
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DISCUSSION 
Skeletal  muscle  relaxants  are  drugs  that  are  able  to 
reduce  unwanted spasm or spasticity with  out  
interfering  with consciousness and  normal voluntary 
movements finds  an important  application in  various 
neurological or  painful  musculo – skeletal disorders. 5  
The  first competitive blocking  agent which  was 
developed  was d-tubocurarine . Presently it  is not  
used  as it   produces  hypotension due  to  histamine 
release  and  ganglion blocking property. The newer  
competitive blockers  pancuronium , vecuronium  and  
atracurium which  were  developed  used  
therapeutically have  less or no histamine releasing 
property. 
The   therapeutically   used   doses   of   pancuronium, 
vecuronium  and atracurium  for initiation  of  skeletal 
muscle relaxation   in human  beings  are   0.08 - 
0.1mg/kg i.v,           0.1mg/kg i.v   and   0.5mg/kg  i.v   
respectively.
6,7 
Isolated  frog rectus abdominis  muscle motor end plate 
contain  nicotinic N-type of acetylcholine  receptors. 
Acetylcholine produces contraction of  frog rectus 
abdominis muscle  by stimulating  the  nicotinic 
receptors  present at  the  motor end   plate  of   isolated 
frog rectus   abdominis muscle. 
The half maximal inhibitory concentration (IC50) is a 
measure of the effectiveness of a substance in inhibiting 
a specific biological or biochemical function.This 
quantitative measure indicates how much of a particular 
drug or other substance (inhibitor) is needed to inhibit a 
given biological process (or component of a process, i.e. 
an enzyme ,cell, cell receptor or microorganism) by 
half. It is commonly used as a measure of antagonist 
drug potency in pharmacological research. 
Height of acetylcholine induced contraction on frog 
rectus muscle is most common method for testing the 
antagonism of neuromuscular blocking agent in 
biological animal. Among the three competitive 
blockers pancuronium appears euipotent to vecuronium 
as maximal reduction in IC50  (Half maximal inhibitory 
concentration )  value of acetylcholine with dose 
concentration of 256µg (table-5 and table-6). 
Atracurium (table-7) is less potent than pancuronium 
and  vecuronium as evident by increase in IC50  (Half 
maximal inhibitory concentration ). 
CONCLUSION 
Pancuronium,  vecuronium and  atracurium  reduced the 
height of acetylcholine induced contractions  on isolated  
frog rectus  abdominis muscle  in a dose dependent 
manner. Pancuronium and vecuronium showed more 
significant promising neuromuscular blocking property. 
How ever further invitro/invivo studies in other 
experimental models may be required  to  conform  the 
potency of all the three neuromuscular  blocking drugs. 
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